Transforming HIV
Our efforts span the full continuum of HIV care – from prevention to treatment to working toward the ultimate goal: a cure. Beyond the science, we partner with like-minded stakeholders to contribute ending HIV as a global public health threat by 2030.
Chronic Hepatitis
With the same tenacity, innovation and focus that drove our work in HIV, we relentlessly work to address the needs and transform care for people with chronic hepatitis.
Treating the COVID-19 Public Health Crisis
We are committed to tackling the COVID-19 pandemic, applying our deep antiviral knowledge and relentless innovation. We are studying ways to enhance the disruption of viral replication advancing novel treatments to help more people.
stopthevirus.eu provides information on Gilead engagement in the health policy landscape regarding communicable diseases. It features policy recommendations and reports from Gilead’s activities across Europe.
Gilead has been, is, and will be here to fight alongside policymakers, nurses, clinicians and campaigners to address the outstanding challenges in the field of virology. Without relentless collaboration and partnership, we could not have come this far.
At Gilead we believe that the impossible is not impossible. It’s what’s next.